Covidien Gets Form 483 for Design, Installation Problems

The GMP Letter
FDA inspectors hit Covidien with a Form 483 for inadequate complaint evaluation and process control procedures, as well as failure to ensure appropriate design and installation of manufacturing equipment.

To View This Article:


Subscribe To The GMP Letter

Buy This Article Now

Add this article to your cart for $157.00